Table 4 Individuals with T2D who were prescribed certain antidiabetic medication and inter-practice variation
N (%) | Minimum–maximum range | Median (IQR) | |
|---|---|---|---|
Individuals with T2D in the study | 23,036 (100.0) | 15—370 | 133 (95—179) |
who were prescribed DPP-4ins | 8,068 (35.0) | 3—130 | 43 (30—64) |
who were prescribed SGLT2ins | 4,828 (21.0) | 1—80 | 25 (15—40) |
who were prescribed GLP-1 RAs | 3,324 (14.4) | 0—93 | 15 (10—25) |
who were prescribed GLP-1 RAs and SGLT2ins combined | 1,641 (7.1) | 0—60 | 6 (3—12) |